Plastic Surgery - Integrated·Galveston, TX

University of Texas Medical Branch Hospitals

Signal lift20%71%+51 pp with a signal here
Allocate signal →Track an away here24-25 cycle · program-reported
Step 2 invited
p10 – p90
Interviewed
48
interviewed (latest year)
This cycle
no tracked aways yet
Match rate
8.3%
4 of 48 interviewed
01Cohort funnel24-25 cycle · program-reported
N = 48 interviewed
Interviewed
48
100.0%
Class size
4
8.3%
J-1 visaCategorical
Your fitUniversity of Texas Medical Branch Hospitals Program

Create a free profile to see your personalized fit

Get started
Contact
DD
Program Director
Daniel Donato, MD
Email director
LP
Program Coordinator
LaNette Patton
Email coordinator
Training sites5 hospitals · Houston
  • 1
    University of Texas Medical Branch Hospitals
    Galveston, TX
    Primary
  • 2
    St Joseph Medical Center
    Houston, TX
    Participant
  • 3
    University of Texas M D Anderson Cancer Center
    Houston, TX
    Participant
  • 4
    Shriners Hospitals for Children (Galveston Burns Institute)
    Galveston, TX
    Participant
  • 5
    Houston Plastic and Reconstructive Surgery
    Houston, TX
    Participant
Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates
US MD
0%
US DO
0%
US IMG
0%
Non-US IMG
0%
Interview prepPlastic Surgery - Integrated
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Save this program

Add University of Texas Medical Branch Hospitals to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Plastic Surgery - Integrated.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.